Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
121.34
-1.60 (-1.30%)
At close: Nov 16, 2026, 4:00 PM EST
121.34
0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM EST

Haemonetics Revenue

Haemonetics had revenue of $357.76M in the quarter ending September 26, 2026, with 9.30% growth. This brings the company's total for the last twelve months to $1.38B, up 4.11% year-over-year. In the fiscal year ending March 28, 2026, Haemonetics had annual revenue of $1.33B, down -1.97%. That makes Haemonetics the 6,311th largest company in the world by revenue and 1,574th in the United States.

Revenue (ttm)
$1.38B
Revenue Growth
+4.11%
P/S Ratio
4.00
Revenue / Employee
$459,441
Employees
3,009
Market Cap
5.53B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Hospital 588.30M 44.1%
  • Plasma 524.46M 39.3%
  • Blood Center 221.27M 16.6%

By Geography

Chart
  • United States Net 982.18M 73.6%
  • Europe Net 185.02M 13.9%
  • Asia Net 87.21M 6.5%
  • Japan Net 68.20M 5.1%
  • Other Geographic Net 11.42M 0.9%
Fiscal year ended Mar 28, 2026 See the full Haemonetics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 28, 20261.33B-26.80M-1.97%
Mar 29, 20251.36B51.77M3.95%
Mar 30, 20241.31B140.40M12.01%
Apr 1, 20231.17B175.46M17.67%
Apr 2, 2022993.20M122.73M14.10%
Apr 3, 2021870.46M-118.02M-11.94%
Mar 28, 2020988.48M20.90M2.16%
Mar 30, 2019967.58M63.66M7.04%
Mar 31, 2018903.92M17.81M2.01%
Apr 1, 2017886.12M-22.72M-2.50%
Apr 2, 2016908.83M-1.54M-0.17%
Mar 28, 2015910.37M-28.14M-3.00%
Mar 29, 2014938.51M46.52M5.22%
Mar 30, 2013891.99M164.15M22.55%
Mar 31, 2012727.84M51.15M7.56%
Apr 2, 2011676.69M31.26M4.84%
Apr 3, 2010645.43M47.55M7.95%
Mar 28, 2009597.88M81.44M15.77%
Mar 29, 2008516.44M66.83M14.86%
Mar 31, 2007449.61M29.87M7.12%
Apr 1, 2006419.73M36.14M9.42%
Apr 2, 2005383.60M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.